Ichiyoshi Y, Zhou M, Casali P
Department of Pathology, Cornell University Medical College, New York, NY 10021.
J Immunol. 1995 Jan 1;154(1):226-38.
We analyzed the structural correlates underlying the insulin-dependent selection of the specific anti-insulin IgG1 kappa mAb13-producing cell clone, derived from a patient with insulin-dependent diabetes mellitus treated with recombinant human insulin. First, we cloned the germ-line genes that putatively gave rise to the expressed VH and V kappa segments and used them to generate the full (unmutated) "germ-line revertant" of the "wild-type" (somatically mutated) mAb13, using recombinant PCR methods and an in vitro human C gamma 1 and C kappa expression system. The full "germ-line revertant" bound insulin specifically and in a dose-saturable fashion, but with a relative avidity (AVrel) more than three-fold lower than that of its wild-type counterpart (Avrel, 1.69 x 10(-8) vs 4.91 x 10(-9) g/microliters). Second, we established, by reassorting wild-type and germ-line revertant forms of the mAb13 VH and V kappa segments, that the increased Avrel for insulin of mAb13 when compared with its full "germ-line revertant" counterpart was entirely dependent on the mutations in the VH not those in the V kappa chain. Third, we determined, by site-directed mutagenesis experiments, that of the three mutations in the mAb13 VH segment (Ser-->Gly, Ser-->Thr, and Ser-->Arg at positions 31, 56, and 58, respectively), only Arg58 was crucial in increasing the mAb13 Avrel (from 1.44 x 10(-8) to 5.14 x 10(-9) g/microliters) and affinity (Kd, from 189 to 59 nM) for insulin. The affinity enhancement mediated by the VH segment Arg58 residue reflected about a threefold decrease in dissociation rate constant (Koff, from 4.92 x 10(-3) to 1.54 x 10(-3) s-1) but not an increase in association rate constant (Kon, from 2.60 x 10(4) to 2.61 x 10(4) M-1 s-1), and it contrasted with the complete loss of insulin binding resulting from the substitution of the VH segment Asn52 by Lys. The present findings suggest that human insulin, a self Ag, has the potential to recruit a natural autoantibody-producing cell precursor expressing a specific surface receptor for Ag in unmutated configuration, and drive it through affinity maturation. They also show that binding of insulin by such a receptor can be enhanced or completely abrogated by a single amino acid change.
我们分析了源自一名接受重组人胰岛素治疗的胰岛素依赖型糖尿病患者的、产生特异性抗胰岛素IgG1 κ单克隆抗体mAb13的细胞克隆在胰岛素依赖选择过程中的结构关联因素。首先,我们克隆了可能产生所表达的VH和Vκ片段的种系基因,并使用重组PCR方法和体外人Cγ1和Cκ表达系统,用它们生成了“野生型”(体细胞突变型)mAb13的完整(未突变)“种系回复突变体”。完整的“种系回复突变体”能特异性且以剂量饱和方式结合胰岛素,但其相对亲和力(AVrel)比野生型对应物低三倍多(AVrel,1.69×10−8对4.91×10−9 g/微升)。其次,通过对mAb13的VH和Vκ片段的野生型和种系回复突变体形式进行重排,我们确定mAb13与完整的“种系回复突变体”对应物相比,其对胰岛素的AVrel增加完全依赖于VH中的突变,而非Vκ链中的突变。第三,通过定点诱变实验,我们确定在mAb13 VH片段中的三个突变(分别在第31、56和58位的Ser→Gly、Ser→Thr和Ser→Arg)中,只有Arg58对增加mAb13对胰岛素的AVrel(从1.44×10−8到5.14×10−9 g/微升)和亲和力(Kd,从189到59 nM)至关重要。由VH片段Arg58残基介导的亲和力增强反映了解离速率常数(Koff)降低约三倍(从4.92×10−3到1.54×10−3 s−1),但结合速率常数(Kon)没有增加(从2.60×104到2.61×104 M−1 s−1),这与用Lys替代VH片段Asn52导致胰岛素结合完全丧失形成对比。目前的研究结果表明,人胰岛素作为一种自身抗原,有可能招募一个表达未突变构型的特异性抗原表面受体的天然自身抗体产生细胞前体,并驱动其进行亲和力成熟。它们还表明,这种受体与胰岛素的结合可因单个氨基酸变化而增强或完全消除。